NDC 83301-0010-01 - Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0010
- Requested NDC
- 83301-0010-01
- Package NDCs from labels
- 83301-0010-1, 83301-0010-2, 83301-0010-3, 83301-0010-01
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd.
- Effective date
- 2025-10-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd. | 2025-10-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0010-1 | Metformin Hydrochloride | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 83301-0010-2 | Metformin Hydrochloride | 500 in 1 BOTTLE | TABLET, COATED | 500 | 6 | |
| 83301-0010-3 | Metformin Hydrochloride | 1000 in 1 BOTTLE | TABLET, COATED | 1000 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0010 | METFORMIN HYDROCHLORIDE TABLET, COATED [MULLAN PHARMACEUTICAL INC.] | 4 | Current NDC, 3 package rows | 20240324_082b4de9-e452-fe71-e063-6394a90ac863.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0010-1 | EA - Each | 83301-0010 | 16a38516-a7c6-4f11-a655-118b462e675b | 1 | 2025-07-08 |
| 83301-0010-2 | EA - Each | 83301-0010 | 307aab11-49de-46b6-830e-891e28249164 | 1 | 2025-07-08 |
| 83301-0010-3 | EA - Each | 83301-0010 | 42878dc7-95f7-406b-9955-4ba3dccd61e3 | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | MICRO LABS LIMITED | fb90693a-074a-45be-94f4-ed6298b1f4e4 | 2026-03-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin HCL | METFORMIN HCL | Direct_Rx | 498ac5fc-14be-d36a-e063-6394a90a3012 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | abd0dad9-5f29-4102-a099-dce7bdddb98b | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| Leader Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Cardinal Health | 5c5d6c13-9b51-48f0-8627-b60b0f707fd3 | 2026-03-12 | Warnings | FZ989GH94E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Legacy Pharmaceutical Packaging, LLC | b51da8d7-ab4a-4c40-97c9-88bd379366d1 | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | 861007 861010 861004 786Z46389E |
| Metformin | METFORMIN ER 500 MG | Legacy Pharmaceutical Packaging, LLC | d9e0816d-fd61-1ac2-e053-2995a90a4054 | 2026-03-11 | Warnings, Adverse reactions | 786Z46389E |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 4a2d814b-93a1-4487-b789-dbafe9f0ffd3 | 2026-03-07 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | 3NXW29V3WO |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | direct rx | c33e24e9-0441-6b94-e053-2a95a90a9c68 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | 861007 861010 861004 786Z46389E |
| glyburide-metformin hydrochloride | GLYBURIDE-METFORMIN HYDROCHLORIDE | A-S Medication Solutions | f43c087a-7135-4a79-8463-fe5e9319da91 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 75b25738-31e6-4b58-9d2b-f4a1ab4ab090 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride Oral Solution | METFORMIN HYDROCHLORIDE | Bionpharma Inc., | 3ab005d4-bc99-4fdb-e063-6394a90a5124 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Method Pharmaceuticals, LLC. | 4aa880a4-7ec0-9155-e063-6394a90a8f3e | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glyburide and Metformin Hydrochloride | GLYBURIDE AND METFORMIN HYDROCHLORIDE | A-S Medication Solutions | d87dade1-55fe-4e77-91b9-b642022a2b8a | 2026-02-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Sportpharm LLC | 8d58dcbb-72a0-41f0-9eeb-613072a6d7ae | 2026-02-06 | Warnings | FZ989GH94E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 239834b0-121a-4903-b3ee-90bb4db4753b | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 5f2023d2-05ae-489d-9e18-fb75057496bc | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| MINIDROPS | LUBRICANT EYE DROPS | Optics Laboratory, Inc | c13c5f91-50df-471c-a7c9-1747a2ac1250 | 2026-02-03 | Warnings | FZ989GH94E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 1d7556eb-82b4-4085-b0b1-dc061b216feb | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 861004 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | GLENMARK PHARMACEUTICALS INC., USA | 0ef9de1a-b786-4b6c-a250-3f5ac532b16a | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.